跳转至内容
Merck
CN

主要文件

查看所有文档

190144

氯铬酸吡啶盐

98%

别名:

PCC

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
C5H6NClCrO3
化学文摘社编号:
26299-14-9
分子量:
215.56
UNSPSC Code:
12352005
NACRES:
NA.22
PubChem Substance ID:
24851416
EC Number:
247-595-5
Beilstein/REAXYS Number:
7054643
MDL number:
MFCD00013106
Assay:
98%
Form:
solid
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

Quality Level

100

assay

98%

form

solid

reaction suitability

reagent type: oxidant

mp

205-208 °C (lit.)

SMILES string

O[Cr](Cl)(=O)=O.c1ccncc1

InChI

1S/C5H5N.ClH.Cr.H2O.2O/c1-2-4-6-5-3-1;;;;;/h1-5H;1H;;1H2;;/q;;+2;;;/p-2

InChI key

JWIPGAFCGUDKEY-UHFFFAOYSA-L

General description

PCC是一种重要的有机试剂，用于氧化反应。

Application

用于由 D-葡萄糖经 Grubbs 催化闭环复分解反应合成 α,β-不饱和内酯过程中氧化烯丙基亚甲基。
稳定的多功能氧化剂，用于醇类的温和选择性氧化。

signalword

Danger

Hazard Classifications

Aquatic Acute 1 - Aquatic Chronic 1 - Carc. 1B Inhalation - Ox. Sol. 2 - Skin Sens. 1

存储类别

5.1B - Oxidizing hazardous materials

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
STBL2233
STBK6695
STBK3098
0000109041
0000109037

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

商品

Oxidizing and Reducing Agents

Oxidation and reduction reactions are some of the most common transformations encountered in organic synthesis

Artur Włodarczyk et al.
Communications biology, 3(1), 215-215 (2020-05-10)
Cyanobacteria, which use solar energy to convert carbon dioxide into biomass, are potential solar biorefineries for the sustainable production of chemicals and biofuels. However, yields obtained with current strains are still uncompetitive compared to existing heterotrophic production systems. Here we
J Nwando Olayiwola et al.
Journal of telemedicine and telecare, 25(8), 493-498 (2018-07-12)
Electronic consultations (eConsults) provide asynchronous, store-and-forward communication between primary care clinicians (PCCs) and specialists using web-based platforms, electronic health records or mobile applications. eConsults have demonstrated benefits in many areas of the Quadruple Aim, including educational value for PCCs. In
Atul Verma et al.
JAMA surgery, 153(6), 577-585 (2018-05-02)
Non-vitamin K oral anticoagulants (NOACs) are increasingly prescribed for patients to treat or prevent arterial or venous thromboembolism. The following 4 NOAC agents are approved by the US Food and Drug Administration for clinical use: dabigatran etexilate, apixaban, edoxaban tosylate
查看所有相关文献

全球贸易项目编号

货号GTIN
190144-100G04061838759665
190144-500G04061838759689
190144-25G04061838759672